Home > Insider Trading > Filing (0001179110-11-004248)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884629	Watson Pharmaceuticals Inc	WPI	Pharmaceutical Preparations (2834)	953872914

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241751	A David Buchen	C/O Watson Pharmaceuticals, Inc. 311 Bonnie Circle Corona CA 92880	Sr. Vp, General Counsel & Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.0033	Acquisiton	2011-03-02	15,034	$0.00	67,100	No	4	A	Direct
Common Stock, Par Value $0.0033	Acquisiton	2011-03-03	5,000	$48.90	72,100	No	4	M	Direct
Common Stock, Par Value $0.0033	Disposition	2011-03-03	5,000	$57.11	67,100	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0033	Non-Qualified Options to Purchase Common Stock	Disposition	2011-03-03	5,000	$0.00	5,000	$48.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-03-23	2011-03-23	No	4	M	Direct

Footnotes

These restricted shares of common stock, par value $0.0033, were issued pursuant to the provisions of the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. and will vest fifty percent (50%) on the second anniversary of the award date and fifty percent (50%) on the fourth anniversary of the award date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.10 to $57.14, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Includes shares of restricted stock issued pursuant to the Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.